Proceeds from a recent European public offering will fund commercialization of the French company's Ikoniscope20 platform in the US and EU.
Sysmex also recently formed a companion diagnostic development partnership with Qiagen, which could help with its efforts in this area.
Understanding how an AI-driven algorithm makes its decisions may help inspire greater physician confidence in the technology.
The assay from a Stanford and UCSF team allows clinicians to scan for multiple cancers of the central nervous system and to reanalyze past samples.
Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response.
In data presented at the ESMO Congress, a signature of eight proteins and two clinical parameters appeared to differentiate responders and non-responders.
The device uses the Chinese-American company's "cancer differentiation analysis" technology and may enable earlier, more robust cancer detection.
A new digital and microfluidic ELISA technique optimized for bedside diagnostics offers high sensitivity at low cost with fast turnaround times.